1. 1605PDHealth-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line. (23rd October 2018) Authors: Grünwald, V; Schuler, M; Schöffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L H; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Richter, S; Kneba, M; Egerer, G; Zimmermann, S; Karch, A; Kunitz, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1606PDQuality of life in patients with soft tissue sarcoma undergoing palliative treatment: A multicenter, cluster-randomized trial within the Germany Interdisciplinary Sarcoma Group (GISG-12). (23rd October 2018) Authors: Hentschel, L; Richter, S; Kopp, H-G; Kasper, B; Kunitz, A; Grünwald, V; Kessler, T; Chemnitz, J-M; Pelzer, U; Schuler, U S; Freitag, J; Schilling, A; Hornemann, B; Arndt, K; Ehninger, G; Bornhäuser, M; Schuler, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1715PSoft tissue sarcomas express a distinct mRNA immune profile. (1st October 2019) Authors: Grünwald, V; Laenger, F; Kunitz, A; Schuler, M; Schoeffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Kneba, M; Egerer, G; Zimmermann, S; Ivanyi, P; Karch, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Zero Energy House for and by Frank Gehry. (June 2019) Authors: Schuler, M; Dvořáková, K; Malík, Z Journal: IOP conference series Issue: Volume 290(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer. (11th February 2019) Authors: Wiesweg, M; Mairinger, F; Reis, H; Goetz, M; Walter, R F H; Hager, T; Metzenmacher, M; Eberhardt, W E E; McCutcheon, A; Köster, J; Stuschke, M; Aigner, C; Darwiche, K; Schmid, K W; Rahmann, S; Schuler, M Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗